Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and ImplementationRoger S. McIntyre, Stephen M. Stahl, James W. Murrough et al.|American Journal of Psychiatry|2021Cited by 707
Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer AgentsGeorge I. Papakostas, Richard C. Shelton, Michael E. Thase et al.|Biological Psychiatry|2007Cited by 302